基于基因表达特征预测局部晚期鼻咽癌远处转移的建立与验证:回顾性多中心队列研究
该多中心回顾性队列研究纳入937例局部晚期鼻咽癌患者,通过微阵列分析识别差异表达基因,构建13基因远处转移基因特征(DMGN),在训练队列及内外部验证队列中验证其预后准确性,并探索其预测同期化疗获益的能力。
要点
- DMGN由13个基因构成,可将患者分为高、低风险组。
核心结论
- DMGN是局部晚期鼻咽癌远处转移的可靠预后工具,可能预测同期化疗获益。
研究设计与样本
- 多中心回顾性队列分析,纳入中国三家医院937例局部晚期鼻咽癌患者。
- 使用微阵列分析24对配对肿瘤的mRNA表达,训练队列(n=410)构建基因分类器。
- 内部验证队列(n=204)和两个外部独立队列(桂林n=165;佛山n=158)验证预后准确性。
主要发现
- 识别137个在转移与非转移组织间差异表达的基因。
关键数值与推荐
- DMGN由13个基因组成,将患者分为高风险和低风险组。
- 列线图基于DMGN及其他变量预测个体远处转移风险,加入EB病毒DNA状态后增强。
临床怎么用
- DMGN可用于局部晚期鼻咽癌远处转移风险分层。
- 低风险患者可能从同期化疗中获益,高风险患者未显示同期化疗获益。
- 列线图结合EB病毒DNA状态可辅助个体化风险预测。
局限性
- 回顾性队列设计。
- 训练队列中高风险组与低风险组的生存比较未报告具体生存率数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gene expression patterns can be used as prognostic biomarkers in various types of cancers. We aimed to identify a gene expression pattern for individual distant metastatic risk assessment in patients with locoregionally advanced nasopharyngeal carcinoma. METHODS: In this multicentre, retrospective, cohort analysis, we included 937 patients with locoregionally advanced nasopharyngeal carcinoma from three Chinese hospitals: the Sun Yat-sen University Cancer Center (Guangzhou, China), the Affiliated Hospital of Guilin Medical University (Guilin, China), and the First People's Hospital of Foshan (Foshan, China). Using microarray analysis, we profiled mRNA gene expression between 24 paired locoregionally advanced nasopharyngeal carcinoma tumours from patients at Sun Yat-sen University Cancer Center with or without distant metastasis after radical treatment. Differentially expressed genes were examined using digital expression profiling in a training cohort (Guangzhou training cohort; n=410) to build a gene classifier using a penalised regression model. We validated the prognostic accuracy of this gene classifier in an internal validation cohort (Guangzhou internal validation cohort, n=204) and two external independent cohorts (Guilin cohort, n=165; Foshan cohort, n=158). The primary endpoint was distant metastasis-free survival. Secondary endpoints were disease-free survival and overall survival. FINDINGS: We identified 137 differentially expressed genes between metastatic and non-metastatic locoregionally advanced nasopharyngeal carcinoma tissues. A distant metastasis gene signature for locoregionally advanced nasopharyngeal carcinoma (DMGN) that consisted of 13 genes was generated to classify patients into high-risk and low-risk groups in the training cohort. Patients with high-risk scores in the training cohort had shorter distant metastasis-free survival (hazard ratio [HR] 4·93, 95% CI 2·99-8·16; p<0·0001), disease-free survival (HR 3·51, 2·43-5·07; p<0·0001), and overall survival (HR 3·22, 2·18-4·76; p<0·0001) than patients with low-risk scores. The prognostic accuracy of DMGN was validated in the internal and external cohorts. Furthermore, among patients with low-risk scores in the combined training and internal cohorts, concurrent chemotherapy improved distant metastasis-free survival compared with those patients who did not receive concurrent chemotherapy (HR 0·40, 95% CI 0·19-0·83; p=0·011), whereas patients with high-risk scores did not benefit from concurrent chemotherapy (HR 1·03, 0·71-1·50; p=0·876). This was also validated in the two external cohorts combined. We developed a nomogram based on the DMGN and other variables that predicted an individual's risk of distant metastasis, which was strengthened by adding Epstein-Barr virus DNA status. INTERPRETATION: The DMGN is a reliable prognostic tool for distant metastasis in patients with locoregionally advanced nasopharyngeal carcinoma and might be able to predict which patients benefit from concurrent chemotherapy. It has the potential to guide treatment decisions for patients at different risk of distant metastasis. FUNDING: The National Natural Science Foundation of China, the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period, the Natural Science Foundation of Guang Dong Province, the National Key Research and Development Program of China, the Innovation Team Development Plan of the Ministry of Education, the Health & Medical Collaborative Innovation Project of Guangzhou City, China, and the Program of Introducing Talents of Discipline to Universities.
引用
- Tang XR, Li YQ, Liang SB, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018. PMID: 29428165. doi:10.1016/S1470-2045(18)30080-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。